NVTA
$26.85
Invitae
$.09
.34%
NVTA
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.71)
Revenue:  $108.89 Mil
Tuesday
Aug 3
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when NVTA reports earnings?
Beat
Meet
Miss

Where is NVTA's stock price going from here?
Up
Flat
Down
Stock chart of NVTA
Analysts
Summary of analysts' recommendations for NVTA
Score
Grade
Pivots
Resistance
$28.61
$28.17
$27.47

$27.02

Support
$26.32
$25.88
$25.17
Tweet
Growth
Description
Invitae Corporation is engaged in genetic diagnostics for hereditary disorders which include breast, colon and pancreatic cancer. It operates primarily in the United States, Israel and internationally. Invitae Corporation is headquartered in San Francisco, California.
Peers
Quest DiagnosticsLaboratory Corp. of America